Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Biohaven Pharmaceuticals, Inc.)"
Count: 50
Selected: 0
| NCT ID | Title |
|---|
| NCT05262517 | Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders | ||
| NCT05248997 | Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis | ||
| NCT05217927 | Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens | ||
| NCT05198245 | Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy | ||
| NCT05156398 | Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects | ||
| NCT05046613 | Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant | ||
| NCT05518123 | Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications | ||
| NCT05509400 | Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use | ||
| NCT05399485 | Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only) | ||
| NCT05399459 | Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only) | ||
| NCT05371652 | Long-Term Safety Study of BHV3000 for the Acute Treatment of Migraine in Chinese Subjects | ||
| NCT05337553 | A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy | ||
| NCT05086094 | Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA) | ||
| NCT04987944 | Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma | ||
| NCT04743141 | Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine | ||
| NCT04708834 | Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder | ||
| NCT04693351 | Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder | ||
| NCT04641143 | Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder | ||
| NCT04634435 | Autologous Memory-like NK Cell Therapy With BHV-1100 (Formerly KP1237), Low Dose IL-2 in Multiple Myeloma Patients | ||
| NCT04574362 | Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine | ||
| NCT04571060 | Randomized Trial in Adult Subjects With Acute Migraines | ||
| NCT04408794 | Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine | ||
| NCT04346615 | Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen | ||
| NCT03952806 | Study of BHV-3241 in Subjects With Multiple System Atrophy | ||
| NCT03941834 | Trial for Treatment Refractory Trigeminal Neuralgia | ||
| NCT03934086 | An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine | ||
| NCT03872453 | Acute Treatment Trial in Adult Subjects With Migraines | ||
| NCT03829241 | Randomized Trial of Adult Subjects With Generalized Anxiety Disorder | ||
| NCT03732638 | Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults | ||
| NCT03701399 | Troriluzole in Adult Subjects With Spinocerebellar Ataxia | ||
| NCT03605667 | Study of BHV-4157 in Alzheimer's Disease | ||
| NCT03537807 | Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS) | ||
| NCT03520517 | Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS | ||
| NCT03461757 | Trial in Adult Subjects With Acute Migraines | ||
| NCT03299166 | BHV-4157 in Adult Subjects With Obsessive Compulsive Disorder | ||
| NCT03266588 | Open Label Safety Study in Acute Treatment of Migraine | ||
| NCT03237845 | Safety and Efficacy in Adult Subjects With Acute Migraines | ||
| NCT03235479 | Safety and Efficacy Study in Adult Subjects With Acute Migraines | ||
| NCT02960893 | Trial in Adult Subjects With Spinocerebellar Ataxia | ||
| NCT01445067 | Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition | ||
| NCT01430442 | Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine | ||
| NCT04899921 | Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets | ||
| NCT04629950 | Rimegepant in Moderate Plaque-type Psoriasis | ||
| NCT04616456 | Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients | ||
| NCT04436510 | HEALEY ALS Platform Trial - Regimen B Verdiperstat | ||
| NCT03017508 | Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder | ||
| NCT05207865 | Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention | ||
| NCT04804033 | A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention | ||
| NCT04649242 | Randomized Study in Children and Adolescents With Migraine: Acute Treatment | ||
| NCT03970447 | A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma |
